Royalty Pharma PLC (Class A)
Closed
SectorHealthcare
63.87 1.27
Overview
Share price change
24h
Min
62.45
Max
63.92
Income | -589M -295M |
|---|---|
Sales | 44M 674M |
P/E Sector Avg | 32.665 56.659 |
EPS | 1.32 |
Dividend yield | 1.5 |
Profit margin | -43.713 |
Employees | 100 |
EBITDA | -387M 176M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +5.38% upside |
Dividend yield Sector Avg | 1.50% 2.18% |
|---|---|
Next Earnings | 4 lis 2026 |
Next Dividend date | 10 wrz 2026 |
Next Ex Dividend date | 13 lis 2026 |
Market Cap | 2.6B 35B |
|---|---|
Previous open | 62.6 |
Previous close | 63.87 |
News Sentiment
By Acuity
81%
19%
315 / 340 Ranking in Healthcare
Royalty Pharma PLC (Class A) Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Royalty Pharma PLC (Class A) Forecast
Price Target
By TipRanks
12 Months Forecast
Average 65.67 USD 5.38%
High 70 USD
Low 62 USD
Based on 7 Wall Street analysts offering 12 month price targets forRoyalty Pharma PLC (Class A) - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$